Falck Medical, INC, an FDA registered corporation, is a leading developer of innovative medical technologies. FMD technology saves sight and prevents stroke.
Check out our new video series about the Falck Medical Inc FMAT1 Device, featuring Dr. Jim Thimons, Chairman of the National Glaucoma Society
https://t.co/PVK3Wol6xf
https://t.co/xKid2QtZdY
https://t.co/UJOeKn8FQG
https://t.co/U9n27TtA07
https://t.co/RKpt71gZs7
The FMD ODM function diagnosed a patient with reversed right OA blood flow and right ICA stenosis. This prevented the patient from going blind and having a stroke. Click publication link below: https://t.co/6ouNJJVDR8 @CureusMedical#stroke#Neurology#Ophthalmology#optometry
Research presented @ARVOinfo using the FMD technology demonstrated that eye pressure varies with blood pressure and that the GAT does not measure this variation. Therefore, the GAT underestimates IOP. Click link below: https://t.co/WywKPECmPv #glaucoma#Ophthalmology#optometry
Research published in the Journal of Current Glaucoma Practice, using the FMD demonstrates that the IOP rise with steroid use is due to impaired aqueous humor outflow. Click this link to read the full publication: https://t.co/9vBGlYd9bM #glaucoma#Ophthalmology#Optometry
New groundbreaking, FDA cleared technology is available for your use to prevent stroke and blindness from glaucoma. Go to https://t.co/hQPL4ut0JQ for more information, and watch this new video from Channel 3 News: https://t.co/hLc7wNuily #Ophthalmology#Optometry#medicaltech
Please see our video of the FMAT1 device that was highlighted in the product press briefing of the Boston AAO 2021 Meeting @aaopt#optometry#eyecare https://t.co/b7JkzEkyRo
The FMAT1 Tonography function was used to measure Aqueous outflow with two different MIGS device. XEN pre op outflow was 0.16 ul/mmHg, post op outflow day one 0.31 ul/mmHg. IStent pre op outflow was 0.19 ul/mmHg, post op outflow day 1 was 0.38 ul/mmHg.
#glaucoma#ophthalmology
Visit Booth 200 at the 2021 Boston AAO Meeting to see the most innovative eye care device in twenty years: Falck Medical Inc's FMAT1 Multi-Function Device. See poster for special promotions for attendees #optometry#eyecare#tonometer#glaucoma https://t.co/RDLYpFl0Cg
Recent article published in "Modern Optometry" outlines the benefits of using the Falck Medical FMAT1 Device in the diagnosis and management of glaucoma. The technology will be on display at Booth 200 at the Boston AAO 2021 Meeting: https://t.co/xj3qVo413h
#optometry#eyecare
The Falck Medical FMAT1 Serial Tonometer, Ophthalmodynamometer and Tonographer will be showcased during the press briefing at the Boston AAO 2021 Meeting November 4th through the 6th. This technology is revolutionizing eye care. #optometry#eyecare
The FMAT1 Tonography function was used to measure Aqueous outflow with two different MIGS device. XEN pre op outflow was 0.16 ul/mmHg, post op outflow day one 0.31 ul/mmHg. IStent pre op outflow was 0.19 ul/mmHg, post op outflow day 1 was 0.38 ul/mmHg.
#glaucoma#ophthalmology
The Falck Medical FMAT1 Device will showcased in Booth 200 at the Boston 2021 AAO Meeting November 4 - 6. Please stop by to see the most advanced glaucoma management technology ever developed.
#glaucoma#optometry#ophthalmology
The Falck Medical FMAT1 Device is the first and only device cleared by the USFDA for the clinical measurement of Aqueous Humor Outflow. Safety and efficacy was demonstrated in extensive FDA glaucoma trials.
#glaucoma#ophthalmology#optometry#medicine
The Falck Medical, Inc FMAT1 Device is first and only device to receive clearance from the USFDA to clinically measure the outflow of aqueous through the trabecular mesh work. #glaucoma#optometry#ophthalmology#blindness prevention
The primary cause of POAG is impaired aqueous humor outflow through the trabecular meshwork. The FMAT1 device is the first and only device by the FDA to measure outflow. Check it out at https://t.co/hQPL4ut0JQ. #glaucoma#optometry#ophthalmology#modernoptometry